"Receptors, Dopamine D2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.
| Descriptor ID |
D017448
|
| MeSH Number(s) |
D12.776.543.750.670.300.400.500 D12.776.543.750.695.150.400.500 D12.776.543.750.720.330.400.500
|
| Concept/Terms |
Receptors, Dopamine D2- Receptors, Dopamine D2
- Dopamine-D2 Receptor
- Dopamine D2 Receptor
- Receptor, Dopamine-D2
- Dopamine D2 Receptors
- D2 Receptors, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D2 [D12.776.543.750.670.300.400.500]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D2 [D12.776.543.750.695.150.400.500]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D2 [D12.776.543.750.720.330.400.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D2".
This graph shows the total number of publications written about "Receptors, Dopamine D2" by people in this website by year, and whether "Receptors, Dopamine D2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 0 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 2 | 1 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 3 | 1 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D2" by people in Profiles.
-
Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors. Sci Rep. 2024 02 27; 14(1):4820.
-
Chimpanzee Extraversion scores vary with epigenetic modification of dopamine receptor gene D2 (DRD2) and early rearing conditions. Epigenetics. 2022 12; 17(12):1701-1714.
-
PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells. Nat Commun. 2021 11 11; 12(1):6505.
-
Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice. Science. 2021 04 23; 372(6540).
-
Spinal Dopaminergic Mechanisms Regulating the Micturition Reflex in Male Rats with Complete Spinal Cord Injury. J Neurotrauma. 2021 03 15; 38(6):803-817.
-
PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia. Nat Commun. 2020 11 19; 11(1):5903.
-
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane. Nature. 2020 08; 584(7819):125-129.
-
Computational design of G Protein-Coupled Receptor allosteric signal transductions. Nat Chem Biol. 2020 01; 16(1):77-86.
-
Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors. J Biol Chem. 2019 12 13; 294(50):19279-19291.
-
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019 Oct; 145(1):97-105.